文献速递消化内镜消化道肿瘤与早癌

磷酸化支链淀粉作为内镜切除黏膜下注射溶液的前临床研究

Innovative submucosal injection solution for endoscopic resection with phosphorylated pullulan: a preclinical study.
PubMed 文献 · Gastrointest Endosc · 2024-01-13

本研究制备了不同浓度的磷酸化支链淀粉(PPL)溶液,在离体猪胃中评估黏膜抬举能力,并在活猪胃和结直肠中行EMR和ESD评估实用性。PPL溶液黏度极低,0.7% PPL的黏膜抬举能力与0.4%透明质酸钠相似,且注射阻力更小、圈套切除更容易、ESD气泡更少、手术时间有缩短趋势。

要点

  • 0.7% PPL黏膜抬举能力与0.4%透明质酸钠相似。
  • 0.7% PPL导管注射阻力小于0.4%透明质酸钠和0.6%海藻酸钠。
  • 活猪EMR中0.7% PPL圈套切除比0.4%透明质酸钠更容易。

核心结论

  • PPL溶液是一种创新且易用的黏膜下注射溶液。

研究设计与样本

  • 前临床研究:制备不同浓度PPL溶液测黏度,离体猪胃评估黏膜抬举能力,活猪胃和结直肠行EMR和ESD评估实用性。

主要发现

  • PPL溶液黏度极低于0.4%透明质酸钠和0.6%海藻酸钠溶液。
  • 浓度至0.7%的PPL溶液黏膜抬举能力与0.4%透明质酸钠相似。
  • 0.7% PPL导管注射阻力小于0.4%透明质酸钠和0.6%海藻酸钠。
  • 活猪EMR中0.7% PPL注射后圈套切除比0.4%透明质酸钠更容易。
  • 活猪ESD中0.7% PPL比0.4%透明质酸钠气泡形成更少,手术时间有缩短趋势。

关键数值与推荐

  • 0.7% PPL溶液用于活猪EMR和ESD评估。
  • 对照溶液包括0.4%透明质酸钠、0.6%海藻酸钠和生理盐水。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: A submucosal injection solution is used to assist in endoscopic surgery. The high viscosity of current solutions makes them difficult to inject. In the present study, we developed an extremely low-viscosity, easy-to-use submucosal injection solution using phosphorylated pullulan (PPL). METHODS: The PPL solutions were prepared at different concentrations, and their viscosities were measured. The mucosal elevation capacity was evaluated using excised porcine stomachs. Controls included 0.4% sodium hyaluronate (SH), 0.6% sodium alginate (SA), and saline. To evaluate the practicality, the catheter injectability of 0.7% PPL was measured, and EMR and endoscopic submucosal dissection (ESD) were performed using the stomach and colorectum of live pigs. As controls, 0.4% SH and saline were used. RESULTS: The PPL solutions were of extremely low viscosity compared to the solutions of 0.4% SH and 0.6% SA. Nevertheless, the mucosal elevation capacity of PPL solutions for up to 0.7% concentration was similar to that of 0.4% SH, and 0.7% PPL was less resistant to catheter infusion than 0.4% SH and 0.6% SA. In live pig experiments with endoscopic mucosal resection and ESD, snaring after submucosal injection of 0.7% PPL was easier than with 0.4% SH, ESD with 0.7% PPL produced less bubble formation than with 0.4% SH, and the procedure time tended to be shorter with 0.7% PPL than with 0.4% SH because of the shorter injection time. CONCLUSIONS: The PPL solution is an innovative and easy-to-use submucosal injection solution.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Satomi T, Ochi Y, Okihara T, et al. Innovative submucosal injection solution for endoscopic resection with phosphorylated pullulan: a preclinical study. Gastrointest Endosc. 2024. PMID: 38224821. doi:10.1016/j.gie.2024.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。